Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment

PURPOSE: Somatostatin receptor ligands (SRL) are the first-line medical treatment for acromegaly. Gallbladder alterations are one of most important SRL side effect, but according to some authors growth hormone hypersecretion itself is a risk factor for gallstones. This single center, longitudinal re...

Descripción completa

Detalles Bibliográficos
Autores principales: Prencipe, N., Bona, C., Cuboni, D., Parasiliti-Caprino, M., Berton, A. M., Fenoglio, L. M., Gasco, V., Ghigo, E., Grottoli, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966199/
https://www.ncbi.nlm.nih.gov/pubmed/33164134
http://dx.doi.org/10.1007/s11102-020-01102-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966199/
https://www.ncbi.nlm.nih.gov/pubmed/33164134
http://dx.doi.org/10.1007/s11102-020-01102-7

Ejemplares similares